These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11294512)

  • 1. Failure of traditional trough levels to predict tacrolimus concentrations.
    Macchi-Andanson M; Charpiat B; Jelliffe RW; Ducerf C; Fourcade N; Baulieux J
    Ther Drug Monit; 2001 Apr; 23(2):129-33. PubMed ID: 11294512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
    Brooks E; Tett SE; Isbel NM; Staatz CE
    Clin Pharmacokinet; 2016 Nov; 55(11):1295-1335. PubMed ID: 27138787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies.
    Saint-Marcoux F; Knoop C; Debord J; Thiry P; Rousseau A; Estenne M; Marquet P
    Clin Pharmacokinet; 2005; 44(12):1317-28. PubMed ID: 16372829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population pharmacokinetic model of cyclosporine in the early postoperative phase in patients with liver transplants, and its predictive performance with Bayesian fitting.
    Charpiat B; Falconi I; Bréant V; Jelliffe RW; Sab JM; Ducerf C; Fourcade N; Thomasson A; Baulieux J
    Ther Drug Monit; 1998 Apr; 20(2):158-64. PubMed ID: 9558129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients.
    Willis C; Staatz CE; Tett SE
    Ther Drug Monit; 2003 Apr; 25(2):158-66. PubMed ID: 12657909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forecasting of blood tacrolimus concentrations based on the Bayesian method in adult patients receiving living-donor liver transplantation.
    Fukudo M; Yano I; Fukatsu S; Saito H; Uemoto S; Kiuchi T; Tanaka K; Inui K
    Clin Pharmacokinet; 2003; 42(13):1161-78. PubMed ID: 14531726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of population pharmacokinetic models of tacrolimus in Thai adult liver transplant recipients.
    Komenkul V; Sukarnjanaset W; Komolmit P; Wattanavijitkul T
    Eur J Clin Pharmacol; 2024 Aug; 80(8):1229-1240. PubMed ID: 38695888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
    Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of tacrolimus in adult renal transplant recipients.
    Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V
    Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation.
    Han N; Ha S; Yun HY; Kim MG; Min SI; Ha J; Lee JI; Oh JM; Kim IW
    Basic Clin Pharmacol Toxicol; 2014 May; 114(5):400-6. PubMed ID: 24238261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus Therapy in Adult Heart Transplant Recipients: Evaluation of a Bayesian Forecasting Software.
    Kirubakaran R; Stocker SL; Carlos L; Day RO; Carland JE
    Ther Drug Monit; 2021 Dec; 43(6):736-746. PubMed ID: 34126624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2004; 43(10):623-53. PubMed ID: 15244495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.
    Saint-Marcoux F; Debord J; Undre N; Rousseau A; Marquet P
    Ther Drug Monit; 2010 Apr; 32(2):129-35. PubMed ID: 20110850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
    Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
    Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients.
    Scholten EM; Cremers SC; Schoemaker RC; Rowshani AT; van Kan EJ; den Hartigh J; Paul LC; de Fijter JW
    Kidney Int; 2005 Jun; 67(6):2440-7. PubMed ID: 15882290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A limited sampling strategy to estimate exposure of once-daily modified release tacrolimus in renal transplant recipients using linear regression analysis and comparison with Bayesian population pharmacokinetics in different cohorts.
    Stifft F; Vandermeer F; Neef C; van Kuijk S; Christiaans MHL
    Eur J Clin Pharmacol; 2020 May; 76(5):685-693. PubMed ID: 32020321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
    Saint-Marcoux F; Debord J; Parant F; Labalette M; Kamar N; Rostaing L; Rousseau A; Marquet P
    Ther Drug Monit; 2011 Apr; 33(2):171-7. PubMed ID: 21383655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.